These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32200906)

  • 1. High throughput lipid profiling for subtype classification of hepatocellular carcinoma cell lines and tumor tissues.
    Wang T; Chen X; Luan C; Wu J
    Anal Chim Acta; 2020 Apr; 1107():92-100. PubMed ID: 32200906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface analysis of lipids by mass spectrometry: more than just imaging.
    Ellis SR; Brown SH; In Het Panhuis M; Blanksby SJ; Mitchell TW
    Prog Lipid Res; 2013 Oct; 52(4):329-53. PubMed ID: 23623802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid response of hepatocellular carcinoma cells to anticancer drug detected on nanostructure-assisted LDI-MS platform.
    Wang T; Liu X; Qu X; Li Y; Liang X; Wu J
    Talanta; 2021 Dec; 235():122817. PubMed ID: 34517673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocarcinoma Discrimination by Ratiometric Lipid Profiles Using Tip-Contact Sampling/Ionization Mass Spectrometry.
    Chen X; Gao J; Wang T; Jiang X; Chen J; Liang X; Wu J
    Anal Chem; 2019 Aug; 91(16):10376-10380. PubMed ID: 31356056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.
    Nagai K; Uranbileg B; Chen Z; Fujioka A; Yamazaki T; Matsumoto Y; Tsukamoto H; Ikeda H; Yatomi Y; Chiba H; Hui SP; Nakazawa T; Saito R; Koshiba S; Aoki J; Saigusa D; Tomioka Y
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1(Suppl 1):e8551. PubMed ID: 31412144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Mechanism-Driven Strategy for High-Coverage Detection of Serum Lipids on a Novel SALDI-MS Target.
    Qu X; Wang T; Liu X; Jiang X; Liang X; Wu J
    Anal Chem; 2022 Jun; 94(24):8570-8579. PubMed ID: 35670384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification and prediction of HCC tissues by Raman imaging with identification of fatty acids as potential lipid biomarkers.
    Tolstik T; Marquardt C; Beleites C; Matthäus C; Bielecki C; Bürger M; Krafft C; Dirsch O; Settmacher U; Popp J; Stallmach A
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):407-18. PubMed ID: 25238702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification.
    Hu B; Li H; Guo W; Sun YF; Zhang X; Tang WG; Yang LX; Xu Y; Tang XY; Ding GH; Qiu SJ; Zhou J; Li YX; Fan J; Yang XR
    Int J Cancer; 2020 Mar; 146(6):1606-1617. PubMed ID: 31310010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue Imprinting on 2D Nanoflakes-Capped Silicon Nanowires for Lipidomic Mass Spectrometry Imaging and Cancer Diagnosis.
    Liu X; Chen Z; Wang T; Jiang X; Qu X; Duan W; Xi F; He Z; Wu J
    ACS Nano; 2022 Apr; 16(4):6916-6928. PubMed ID: 35416655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
    Agarwal R; Narayan J; Bhattacharyya A; Saraswat M; Tomar AK
    Cancer Genet; 2017 Oct; 216-217():37-51. PubMed ID: 29025594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Breast Cancer Margins by Tissue Spray Mass Spectrometry.
    Chagovets VV; Starodubtseva NL; Tokareva AO; Frankevich VE; Rodionov VV; Kometova VV; Chingin K; Kukaev EN; Chen H; Sukhikh GT
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
    J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics.
    Li Z; Guan M; Lin Y; Cui X; Zhang Y; Zhao Z; Zhu J
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29182572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade.
    Guan DX; Shi J; Zhang Y; Zhao JS; Long LY; Chen TW; Zhang EB; Feng YY; Bao WD; Deng YZ; Qiu L; Zhang XL; Koeffler HP; Cheng SQ; Li JJ; Xie D
    Hepatology; 2015 Dec; 62(6):1791-803. PubMed ID: 26257239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
    Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ratiometric Mass Spectrometry for Cell Identification and Quantitation Using Intracellular "Dual-Biomarkers".
    Chen X; Wo F; Chen J; Tan J; Wang T; Liang X; Wu J
    Sci Rep; 2017 Dec; 7(1):17432. PubMed ID: 29234137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial analysis by laser desorption ionization mass spectrometry on amorphous silicon.
    Kim SH; Kim J; Jo SH; Kim JH; Kim KJ; Yoon S
    Biointerphases; 2016 Dec; 11(4):041008. PubMed ID: 28006919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-line mixed-mode liquid chromatography coupled with reversed phase high performance liquid chromatography-high resolution mass spectrometry to improve coverage in lipidomics analysis.
    Narváez-Rivas M; Vu N; Chen GY; Zhang Q
    Anal Chim Acta; 2017 Feb; 954():140-150. PubMed ID: 28081809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.